Cancer Terms

Anti-PD-L1 Monoclonal Antibody MDX-1105

Cancer Terms -> Drugs and Chemicals -> Pharmacologic Substance -> Biological Agent -> Monoclonal Antibody -> Anti-PD-L1 Monoclonal Antibody MDX-1105

Anti-PD-L1 Monoclonal Antibody MDX-1105 Definition

A fully human monoclonal antibody directed against the protein ligand PD-L1 (Programmed Death-1 Ligand 1) with immunomodulating and potential antineoplastic activities. Anti-PD-L1 monoclonal antibody MDX-1105 binds to PD-L1, blocking its binding to and activation of its receptor, PD-1 (Programmed Death 1), which may enhance the T-cell-mediated immune response to neoplasms and reverse T-cell inactivation in chronic infectious disease. PD-L1 is expressed broadly on hematopoietic and parenchymal tissues; PD-1, a transmembrane protein, is a negative regulator of the immune system that limits the expansion and survival of CD8+ T cells.

Anti-PD-L1 Monoclonal Antibody MDX-1105 Synonyms

Anti-PD-L1 Monoclonal Antibody MDX-1105, MDX-1105

Terms in Anti-PD-L1 Monoclonal Antibody MDX-1105 category



Copyright © Cancer Terms 2014 All rights reserved. | Terms of Use | Low Carb Foods

No reproduction or republication permitted.